Few oral biologics have made it to market, and though the challenges are well known, the benefits are huge and the task is not impossible. New technologies can help.

Manufacturers have gotten to grips with the complexities of batch-based bioprocesses, but breaking into the realm of continuous bioprocessing can lead to even greater efficiency.

Will future drugs in Europe be priced based on therapeutic outcomes?

Cell therapy successes are widely hailed as breakthroughs, but will adverse effects and patient deaths hold the field back?

VR is creating a buzz, but is it a game changer or gimmick?

Collaboration can be the key to success, but does open innovation truly unlock the right doors?

Power List: Last year many nominated business leaders, but did we miss any important unsung heroes?

How do we move on from a sombre start to 2016?

2015 has been a difficult year for Indian pharma companies – and ASSOCHAM is calling for the country to get its “house in order”.

A capsule being developed in Ireland aims to contain not medicine, but process analytical technology.